The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
about
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinomaAdeno-associated virus-mediated microRNA delivery and therapeuticsIncomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signalingRegulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR systemDecorin deficiency promotes hepatic carcinogenesisRole of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine AminotransferasePygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl.Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrenceγ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway.Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancerA review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatmentHBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.Targeted therapies in the treatment of advanced hepatocellular carcinomaExpression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling.ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.PKM2: a new player in the β-catenin game.Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma.Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance.DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway
P2860
Q26738293-0AB514FD-F67E-45DF-ADCE-06D559142A2FQ26799745-F38EB25E-94E5-413C-898B-30ADFE1E9395Q27005597-AD691DE5-716E-4C4E-8A45-6B41F8F9FB5CQ27318569-3248CA06-18EC-448C-9654-CBE2E6DFF3D3Q28484499-C5E84A11-574E-4CAA-9680-4B00BCE7B1A1Q33690924-F1BBF248-414C-4CC9-981E-30B1829C926AQ33706930-92AE53E8-9CA4-4779-8E82-7467BEEE66DEQ33823661-98D58600-B9A7-428F-8D43-B62438C91B7CQ34306118-1B0EBED5-708D-425C-9E08-3874BB50F1C7Q34409807-5DF3AC6E-891B-499F-A696-C387926F79DEQ35424206-DD8E033F-A535-4385-A8CE-9EBA7049EF79Q35742116-2144CD47-F359-42F2-9CA6-BE6A27103D1DQ35750492-47D18E64-926C-40B8-A641-FCB944DA0060Q35793718-13129B02-1F92-481F-B2D1-896D7A5A90D8Q36624036-1B9886EA-6548-49BE-B5AF-420352D3C61EQ36640592-E55C7655-3E8D-48DC-B8ED-AE420D323427Q36730590-4CBF8B93-1103-45AB-9F69-AD510A8E6F58Q36763380-04E07F25-3844-4A03-B911-8637B22DB52DQ36823677-826EC248-27E1-4882-A838-180C654F1601Q36926103-20E5E858-35F8-4D79-86D1-3378DEA2AD1FQ37031700-9E742E71-4F06-471B-AE18-F0B42B99964FQ37190326-69599EDF-A0AB-4EEB-B579-FEA538FC9AD8Q37375282-8E42316A-6540-40B0-93FA-FD83B67DF217Q38114062-F0BB7677-D284-4F5F-AA0D-9968005DB232Q38727336-C4CE6A64-4045-4939-A2C4-7E3B452A6B84Q38730840-49E0DBD2-7FEF-4AB1-B811-60965819F675Q38899960-F292CD28-CC7A-4209-AA5D-F15EF2E354FBQ38906745-50A64029-DF2E-4913-AAF0-D7A415EF6FB5Q38940925-0D942250-8C9A-43AC-B00E-E34B9B0CD80DQ39062813-936BE05F-D36F-4E4C-8123-DF2BBCB8C761Q39627462-24001066-D72C-4728-B3A2-8701EBFA74C9Q40928864-24947F89-5E75-48EC-B269-9CB3D0CC3246Q42092852-1793A945-8189-4A7B-9EF8-542514597450Q49335033-D420156E-6E2D-48B0-956E-FEF6B5CC9D43Q55428498-318048AC-7FAE-417D-A971-6ED5AAF21D1EQ57074566-3C49F495-BA06-48E7-ABCF-8E748D856BA3
P2860
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@en
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@nl
type
label
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@en
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@nl
prefLabel
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@en
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@nl
P2093
P1476
The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
@en
P2093
Christine Perret
Pierre-Alexandre Just
Rajae Dahmani
P304
P356
10.1016/J.CLINRE.2011.05.010
P577
2011-07-21T00:00:00Z